The G-protein-coupled receptor BLRI related to receptors for chemokines and neuropeptides has been identified as the first lymphocyte-specific member of the gene family characterized by seven transmembrane-spanning regions. Using a high-affinity anti-BLRI monoclonal antibody (MoAb) and three-color flow cytometry it is shown that BLRI expression on peripheral blood cells is limited to B cells and to a subset of CD4+ (1440) and CD8+ (2%) lymphocytes. T cells expressing BLRI were positive for CD45R0, were negative for interleukin-2 receptors, show high levels of CD44, and show low levels of L-selectin. The majority of CD4' cells originating from secondary lymphatic tissue, but none of cord blood-derived T cells, express BLRI. These observa-MMUNOLOGIC memory is one of the key features of the immune system of higher vertebrates and provides a rapid and excellent response of an organism to secondary encounters with pathogens. Despite recent evidence in cloning and analyzing factors involved in differentiation and maturation of both B and T cells, there is still considerable controversy about the phenotype of immunologic memory cell^."^ B cells are rapidly produced by hematopoietic stem cells of the bone marrow and the fetal spleen. However, most of these cells die soon after exit from the marrow and those that survive are considered to reconstitute the red pulp and T-cell-rich zones of the spleen or, in general, to populate secondary lymphatic tissues.""' During the passage from marrow to secondary lymphatic tissue, B cells are selected by ligands as they differ from bone marrow cells in V gene expre~sion.",'~ These cells are considered to be naive and, together with memory cells, they form the stable peripheral B-cell pool. This pool consists of B cells recirculating between lymphatic tissues and of sessile cells of the marginal zone (MZ).l5 After primary contact with an antigen, naive B cells of the T-cell-rich zone are activated and then migrate to follicles where they give rise to the formation of germinal centres. Here, B cells undergo two important changes: hypermutation and selection of high-affinity B cells and generation of memory B cells. Once having entered the follicle, B blasts grow exponentially and populate the follicular dentritic cell (FDC) network, eventually leading to development of the 
MMUNOLOGIC memory is one of the key features of the immune system of higher vertebrates and provides a rapid and excellent response of an organism to secondary encounters with pathogens. Despite recent evidence in cloning and analyzing factors involved in differentiation and maturation of both B and T cells, there is still considerable controversy about the phenotype of immunologic memory cell^."^ B cells are rapidly produced by hematopoietic stem cells of the bone marrow and the fetal spleen. However, most of these cells die soon after exit from the marrow and those that survive are considered to reconstitute the red pulp and T-cell-rich zones of the spleen or, in general, to populate secondary lymphatic tissues.""' During the passage from marrow to secondary lymphatic tissue, B cells are selected by ligands as they differ from bone marrow cells in V gene expre~sion.",'~ These cells are considered to be naive and, together with memory cells, they form the stable peripheral B-cell pool. This pool consists of B cells recirculating between lymphatic tissues and of sessile cells of the marginal zone (MZ).l5 After primary contact with an antigen, naive B cells of the T-cell-rich zone are activated and then migrate to follicles where they give rise to the formation of germinal centres. Here, B cells undergo two important changes: hypermutation and selection of high-affinity B cells and generation of memory B cells. Once having entered the follicle, B blasts grow exponentially and populate the follicular dentritic cell (FDC) network, eventually leading to development of the typical polarized shape of the germinal center. Although still in rapid cell cycle, the centroblasts, unlike their progenitors, the B blasts, do not increase in number and do not express surface Igs. Instead, they give rise to nondividing centrocytes that enter the light zone of germinal centers." It has been assumed that the somatic mutation of Ig V region genes occurs in the centroblasts during this process and that centrocytes are selected on the basis of expressing highaffinity antibodies.
After secondary exposure to antigen, memory B cells might reenter the germinal center via the outer zone of the follicle and undergo another round of hypermutation and clonal proliferation, giving rise to the production of large amounts of high-affinity antibodies." Despite the clear functional definition of memory B cells, their phenotype is still discussed controversially. It is generally believed that memory B cells are long-lived cells expressing sIgG and that sIgM' or sIgD' cells contribute little or nothing to the memory However, stathmokinetic considerations conclude that the fraction of IgG' cells is by far too low to establish and maintain the memory pool. Because the number of IgG+ cells does not increase with age it has been postulated that IgG' cells can re-express sIgM and sIgD molecules."-'x Markers for memory B cells can not be used to identify memory T cells because these markers do not show isotype switching or somatic mutation. A variety of surface molecules has been suggested to characterize memory T cells. These cells are proliferating in response to recall antigens and are thought to express high levels of CD2, CD44, CD29, LFA-I, LFA-3, and VLA4-6, and low levels of L-selectin, CD27, and interleukin-2 (IL-2) receptor.'.' However, CD45RO, a low-weight isoform of the tyrosine phosphatase CD45, has been suggested repeatedly to be the most prominent memory T-cell marker. Interestingly, naive T cells express the high molecular weight isoform of CD45 designated CD45RA.'9~20 In terms of cytokine production memory T cells (CD45RO') express multiple lymphokines (IL-2, IL-3, IL-4, [L-6, y interferon [yIFN], and granulocyte-macrophage colony-stimulating factor [GM-CSF]), whereas naive T cells (CD45RA') mainly produce IL-2.'"" Classically, G-protein-coupled receptors (GCRs) are activated by hormones or neurotransmitters. However, recent 
MATERIALS AND METHODS

Antibodies.
The following antibodies were used in this study: anti-CD3-phycoerythrin (PE), anti-CD4-fluorescein isothiocyanate (FITC), anti-CD8-PE and -FITC, anti-CDlCPE, anti-CD19-anti-Leu8-PE, and anti-IgM were all purchased from Becton Dickinson (Mountain View, CA). Anti-CD10-FlTC, anti-CD20, anti-CD24, anti-CD29-FITC, anti-CD37, anti-CD38-FITC, anti-CD39, anti-CD45RA-FITC, anti-CD45RO-PE, anti-CD72, anti-CD77, goat-antirat (Fab)?-Peroxidase (POD) or -FITC, mouse-antirat-biotin, rat-antimouse-biotin were purchased from Dianova (Hamburg, Germany). Anti-CD5-PE, anti-CD19-PE, anti-CD44-PE, and anti-IgD-Biotin were obtained from Sigma (St Louis, MO). Anti-CD40 was purchased from Serotec (Oxford, UK) and antiIgG-FITC was purchased from Dakopatts (Hamburg, Germany).
Anti-CD76 (clone HD66) was a gift from D r Bernd Diirken (MaxDelbrUck-Centrum, Berlin-Buch, Germany) and anti-CD3 (clone 26-11-8; rat IgGZb) was kindly provided by Dr Rolf Schuh (Fresenius, Munich, Germany). All superparamagnetic-labeled antibodies used were purchased from Miltenyi (Bergisch Gladbach, Germany). Normal tonsil tissues were obtained from tonsillectomies at Munich University Hospital. Tonsil tissues were minced and strained through a stainless steel mesh. To remove debris, cells were centrifuged over a Ficoll cushion as described above. CD19+ B cells were further enriched, as described previously, using the MACS system (Milten~i).'~ In brief, 8 X lo7 tonsillar lymphocytes were incubated with an anti-CDI9-FlTC antibody at 12°C for 15 minutes. After washing once in PBS, 20 ,uL of a superparamagnetic-labeled ratantimouse IgG, antibody was added and the total volume was adjusted to 200 pL. After 15 minutes, cells were washed again and positively enriched on an undersized MACS column with a capacity for 3 X lo7 cells. The resulting cells were typically greater than 98% CD19+ and less than 1% CD3+, as determined by flow cytometry.
Thymic tissue was obtained from children 3 to 5 years of age undergoing cardiovascular surgery at the Deutsches Herzzentrum (Munich, Germany). Suspensions were made as described for tonsillar lymphocytes, but omitting the Ficoll separation step. One part of the suspension was enriched for CD3-CD4-CD8-cells by incubating 2 X lo7 thymocytes with saturating amounts of anti-CD3, anti-CM, and anti-CD8 MoAb for 15 minutes. After one wash, cells were incubated with superparamagnetic-labeled rat-antimouseIgG, and labeled cells were removed by MACS, using an oversized column (capacity, lo8 cells). Cells of the flow-through were collected and analyzed by flow cytometry.
Cell culture. B cells were cultured in Iscove's medium supplemented with 5 pg/mL bovine insulin, 0.5% bovine serum albumin (BSA), 50 pg/mL human transferin, 5 X lo-' m o m P-mercaptoethan01 (&ME) (all from Sigma), and 5% IgG-free FCS (PAA, Linz, Austria), as described el~ewhere.~' All cultures were performed in the presence of irradiated (8,000 rad) CDw32-transfected Ltl-cells (CDw32 L cells), kindly provided by K. Moore (DNAX, Palo Alto, CA). CDw32 L cells were seeded in 48-well flat-bottom microtiter plates at 2 X l@/well 1 day before MACS-separated CD19+ B cells were added at 5 X l@/well. At the beginning of the experiment, 100 U/mL recombinant human interleukin-4 (rhuIL-4; Genzyme, Cambridge, MA) and 1 pg/mL anti-CD40 MoAb (clone B-B20) were added to give a final volume of 500 pL. Half of the supplemented medium was replaced every other day. BLRl expression of triplicate cultures of B cells was monitored over a 10-day period by flow cytometry. T cells were cultured in RPM1 1640 medium supplemented with 10% FCS and 5 X lo-' m o m @ M E . For Tcell activation, 24-well plates were coated overnight with anti-CD3 MoAb (clone 26-11-8; 50 pg/mL in carbonate buffer, pH 9.6). After washing extensively with PBS, PBLs were added at 2.5 X 105/well and BLRl expression of CD3+ cells was monitored as described for B cells.
Immunohistochemisrry. Double-immunoenzymatic labeling was performed in accordance to standard t e c h n i q~e s .~~ Tissue specimens were kept in buffered isotonic solution at 4°C for less than 4 hours until they were snap-frozen in chilled isopenten or directly embedded in tissue tek (Miles, Elkhart, IN), frozen on a mixture of dry ice and ethanol, and stored at -80°C. Acetone-fixed cryostat sections of 10 pm were incubated in 0.3% H202 in PBS for 10 minutes at room temperature (RT) to block endogenous peroxidases. Sections were incubated with the rat anti-BLR1 antibody (10 pg/mL) at RT in a humidified chamber for 1 hour. After three washes in PBS 0.1% Tween 20, a polyclonal goat-antirat F(ab), peroxidase conjugate was For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From 832 FORSTER ET AL added ( I : 100). After I hour, the reaction was visualized using DAB (Sigma). To saturate the goat-antirat conjugate, sections were blocked with 10% rat serum for IS minutes and all subsequent steps were performed in the presence of 10% rat serum. Slides were then incubated with the second primary murine MoAb (1:40 for 1 hour at RT) and, after three washes in Tris-NaCI (pH 7.4), a rat-antimouse-biotin antibody was used ( 1 : 100 for 1 hour at RT). The third layer was a streptavidin-alkaline phosphatase (AP) conjugate (GIBCO, Grand Island, NY; 150 for 45 minutes). After three final rinses, the AP was developed using Fast Red or Fast Blue (Sigma). In single immunoenzymatic labeling experiments using DAB, the bright brown color of the dye was intensified using CuSO, (0.5% in isotonic saline solution; 2 minutes at RT) before sections were counterstained with Mayer's hematoxylin, dehydrated, and mounted in Polymount (Polysciences, Eppelheim, Germany). Photographs were taken with a Leica camera (Bensheim, Germany) or Kappa video camera (CF15/2; Gottingeu, Germany). Digitized images (Photo-CD: Kodak, Munich, Germany) were printed on a Mitsubishi video printer (CP100; Ratingeu, Germany) using a control software for high resolution output (Metzger, Munich, Germany).
Flow cvtometry. For triple-fluorescence analysis, cells were incubated with biotinylated anti-BLR1 MoAb (5 pg/mL) in PBS (4% FCS, 5 mmol/L EDTA, 0.1% NaN3) for 20 minutes at 12°C. Cells were then stained simultaneously with streptavidin-cychrome (1 :200; Pharmingen, San Diego, CA) and further FITC-and/or PE-conjugated primary antibodies (5 pg/mL). In experiments using unconjugated antibodies, cells were incubated with purified antibody and then stained with F(ab)* FITC-conjugated antispecies IgG and IgM. Free binding groups of the secondary antibody were blocked by incubating the cells with 10% serum of the same species from which the primary antibody derived. Cells were subsequently incubated with biotinylated anti-BLRI MoAb and staining with streptavidincychrome was performed as described above.
RESULTS
Expression of BLRl on PBLs. The expression of BLRl on PBLs was examined in nine independent experiments by three-color flow cytometry and the use of B-and T-cellspecific MoAbs. All (range, 99% to 100%) CD19' peripheral B cells expressed BLRl (Fig 1A) . Interestingly, 15% (6% to 22%) of CD4+ T-helper cells (Fig 1B) displayed this receptor, whereas only 2% (1% to 4%) of CD8+ cytotoxic T cells showed BLRl expression (Fig 1C) . It should be noted that expression levels of this receptor were always higher on PBL B cells than on PBL T cells (Fig 1A and B) , and that none of the CD3-CD19-double-negative cells express BLRl (Fig 1D) . Interestingly, PBLs expressing BLRl are generally rather small, as demonstrated by decreased forward scatter intensities (Fig IE) . Neither polymorphonuclear cells (PMN) nor monocytes express any detectable levels of BLRl (data not shown).
Memory T-cell phenotype of BLR1' T cells. The presence or absence of certain isoforms of the common leukocyte antigen CD45 is thought to be a marker for different stages of T-cell activation and differentiation. It has been suggested that CD45RA is mainly expressed on naive T cells, whereas activated and memory T cells express the CD45RO isoform."." Both PBLs and tonsillar lymphocytes were therefore stained with anti-CD45RA-FITC, anti-CD45RO-PE, and anti-BLR1 -biotin/streptavidin-cychrome. Setting gates on BLRl+CD4+ cells showed that about 90% to 97% of these cells of both sources expressed CD45RO (Fig 2A) and that only 12% of BLR1+ CD4+ cells expressed the CD45RA isoform (data not shown). Furthermore, analysis of activated T-helper cells characterized by the presence of IL-2 receptor (IL-2R) molecules (CD25) illustrates that BLRl is not expressed on activated T cells (Fig 2B) . Interestingly, while analyzing PBLs, BLRl expression was found on 23% of CD3+CD45RO', but on less than 2% of CD3TD45RA' T cells (data not shown). This strongly suggests that BLRl identifies a subpopulation of memory T cells.
To further investigate the onset of BLRl expression during T-cell development, thymocyte suspensions were stained with anti-CD4-FITC, anti-CD8-PE, and anti-BLR1-biotin/ streptavidin-cychrome. Eight percent of the CD4+ CD8-cells and 1% of the CD4-CD8' cells coexpressed BLR1. However, immature CD4+CD8+ cells did not express any detectable levels of BLRl (Fig 3A) . pothesis that BLRl is a marker of antigen-experienced memory T cells, cord blood lymphocytes, which are by definition naive, were tested for BLRl expression. It was found that greater than 99% of both CD4+ or CD8+ cord blood lymphocytes were BLR1- (Fig 3B) . Furthermore, analysis of normal BM cells showed that greater than 92% of CD4+ cells and greater than 98% of CD8' cells did not express BLRl (Fig 
L-selectin
where antigen-experienced T-helper cells support B-cell differentiation. Analysis of CD4+ cells in secondary lymphatic organs such as spleen or tonsil showed that 65% of spleen CD4+ cells (data not shown) and 75% of tonsillar CD4+ cells (Fig 3D) are BLRl+, whereas only low percentages for CD8+BLRl+ cells were found (Fig 3D; data for spleen not shown). This finding puts further weight on the hypothesis that the G-protein-coupled receptor BLRl plays a prominent role in T-cell memory. It has been postulated further that long-term memory cells express high levels of CD44,"' high levels of adhesion molecule VLA-4 (CD29);' and low levels of the lymph node homing receptor L-selectin:' Therefore, we used appropriated MoAb to stain cells originating from different lymphatic tissues. We found that 50% to 80% of CD3+BLR1+ cells deriving from PBLs or BM express high levels of CD29, whereas only 7% to 15% of CD3+BLRl+ cells originating from tonsils or thymus express this molecule (data not shown). However, all BLR1+ lymphocytes expressed high levels of CD44 irrespectively of their origin (Fig 4A) and, interestingly, BLR1' cells did not or only moderately expressed L-selectin (Fig 4B) . Taken together, these results suggest again that BLRl is a marker for T-memory cells. CD19, sIgM, or sIgD molecules. High expression levels of BLRl were always associated with cells positive for IgD, which is a marker for mature B cells (Fig 5A) . CD38, a marker of germinal center cells in secondary lymphatic tissue~:~ showed a different correlation with BLR1. Ninetytwo percent of CD38+ cells coexpressed BLR1, although cells with high levels of CD38 only moderately expressed this G-protein-coupled receptor (Fig SA) . A similar coexpression pattern was observed for CD10, an antigen thought to be a marker for B blast in secondary lymphatic tissue. More than 95% of CD10+ tonsillar lymphocytes coexpress BLR1, albeit at moderate levels ( Fig 5A) . The CD77 antigen can be found on a subpopulation of germinal center B cells and is expressed in particular on the centroblasts of the dark zone of the follicle.""' Flow cytometry showed that a high proportion of CD77+ tonsillar lymphocytes express BLRl (data not shown).
To investigate BLRl expression at early stages of B-cell maturation, adult BM cells and cord blood were analyzed by three-color flow cytometry. Experiments using BM or cord blood cells showed that only 20% to 60% of each of the CD19+, CD40+, sIgM+, or sIgD+ cells of both sources coexpress BLRl (Fig 5B, data for BM and sIgD not shown) . These data support the notion that this receptor is expressed exclusively on mature recirculating B cells. For a long time the thymus has been considered to be exclusively a place for T-cell development. However, it was recently shown that low numbers of B cells are also present in this organ.& To investigate thymic B cells for BLRl expression, thymocyte suspensions were depleted for CD3+, CD4+, and CD8+ cells by use of MoAbs and MACS. As shown in Fig SC, (Fig 6A) . Counterstaining with CD38 MoAb confirmed that there are BLRl' cells within the GC and further demonstrates that only a fraction of CD38' cells express BLRl (Fig 6B) . It has been reported that CD76 also stains mantel zone cells of secondary follicles:' but flow cytometry on PBLs showed that BLRl and the CD76 antigen are different epitopes (data not shown). The use of anti-IgD antibody shows that all cells of the mantel zone coexpress BLRl and IgD, whereas IgD' cells of the interfollicular zone do not or weakly stain with BLRl MoAb (Fig 6C) . The use of a CD4 MoAb showed that CD4+BLR1' cells can be found in the T-cell-rich area between the follicles and also in the germinal center (Fig 6D) . Staining of spleen sections shows that BLRl expression is limited to cells of the periarteriolar lymphatic sheath (PALS) and to singular cells of the red pulp (Fig 6E) . Interestingly, cells situated in the centre of PALS express low levels of BLRl compared with cells of the T-cell-rich area of PALS (Fig 6F) .
Downregulation of BLRl on B and T cells.
Functional assays were performed to determine BLRl expression on CD19+ B cells after their differentiation in vitro after ligation of CD40 and the addition of IL-4. For this purpose, 5 X 10s purified B cells were seeded in wells of 48-well trays together with 2 X lo4 irradiated CDw32 L cells and anti-CD40 MoAb and IL-4 (100 UlmL). At days 0, 3, 7, and 9 after culture onset, three wells each were harvested and screened for BLRl expression, using BLRl MoAb and isotype control MoAb. As shown in Fig 7A, BLRl was still highly and homogeneously expressed on activated B cells 3 days after culture onset. However, after 7 days, BLRl could hardly be detected, and was virtually absent after 9 days of culture (Fig 7A) . In a similar type of experiment, T cells were activated by anti-CD3 MoAb and expression of BLRl was monitored over a period of 7 days. As observed for B cells, activation of T cells also led to complete downregulation of BLRl on these cells (Fig 7B) . Despite a transient increase in the number of BLRl ' T cells, 3 days after culture onset expression levels of BLRl were constantly downregulated and the receptor was regularly absent after 5 days (Fig 7B) . No changes in BLRl expression were observed on unstimulated T cells (Fig 7C) .
In earlier studies using the Northern blot hybridization technique, we were not able to demonstrate murine BLRIspecific mRNA in plasmacytoma cell lines.13 To confirm these results, BM cells obtained from a biopsy of a patient with plasmacytoma were analyzed. To allow intracellular antibody staining, one aliquot of the cells was fixed in paraformaldehyde and subsequently permeabilized using Digitonin. The phenotype of the cell population was examined using (among others) CD10 MoAb, CD38 MoAb, anti-lgG antibodies, and BLRl MoAb. Surface analysis showed that cells were stained moderately with anti-CD38 MoAb, weakly with both anti-CD10 MoAb and anti-IgG antibody, but not with BLRl MoAb (Fig 8) . In contrast, all permeabilized cells were homogeneously and brightly stained for CDIO, CD38, and IgG, but these cells stained not specifically with BLRl MoAb (Fig 8) . Taken together, these results clearly indicate that BLR 1 is expressed on mature B cells and expression is downregulated when terminal differentiation to IgG-secreting cells is initiated. B cells express BLRl . Furthermore, because there are still sIgM' B cells in these organs that do not express BLRl, it seems likely that this GCR is first expressed on mature B cells and is present on all recirculating peripheral sIgM+ or CD19' B cells. Flow cytometry and immunohistochemistry of tonsillar lymphocytes showed that BLRl is expressed at high levels on mature resting B cells of the mantle zone, but expression levels are low on germinal center B cells expressing high levels of CD10 or CD38 molecules. This finding suggests that BLRl is gradually downregulated during affinity maturation.
It has been shown that the coculture of resting B cells
For personal use only. on November 11, 2017 . by guest www.bloodjournal.org From with IL-4, MoAbs to CD40, and a mouse fibroblast cell line transfected with human Fcy receptors results in B-cell proliferation and secretion of I~s .~* Using this CD40 system, we were able to show that expression levels of BLRl decrease during B-cell activation. Because none of the cells cultured for 9 days retained detectable levels of BLRI, it seems that triggering of B cells with IL-4 and anti-CD40 MoAb is sufficient to induce downregulation of BLRI. The proposal that BLRl expression ceases during terminal differentiation of B cells towards IgG secreting plasma cells was based on earlier studies because we failed to demonstrate BLR1-specific RNA transcripts in various murine plasmacytoma cell lines." This result was confirmed in the present study because we did not find BLRl molecules on human primary plasmacytoma cells. Interestingly, BLRl is not ex-I SUR L E . Q a, pressed on activated (CD25+) peripheral blood T-helper cells (Fig 2B) , and activation of resting T cells with anti-CD3 MoAb leads to complete downregulation within 5 days. This finding further suggests that BLRl is mainly expressed on resting lymphocytes.
Several families of cell adhesion molecules, including selectins and integrins, are involved in leukocyte trafficking into secondary lymphatic organs and into sites of inflammati~n.''~.~' However, mechanisms controlling targeting of specific lymphocyte effector subpopulations during immune challenge are hardly understood. Recent evidence suggests that members of the chemokine family are involved in this process. It has been demonstrated that IL-8 is a chemoattractant for T cells5' and it has been postulated that RANTES attracts T cells of the memory p h e n~t y p e .~~ Macrophage To date, all information about the distribution of leukocyte-specific G-protein-coupled receptors is based on studies of receptorAigand interactions. The use of a BLR1-specific MoAb allowed us to explore more precisely the expression and regulation of a GCR on lymphatic cells. In addition, BLRl MoAb may be a valuable tool to identify molecular mechanisms of receptor-coupled signal transduction pathways and may help to identify the physiologic ligand for BLR1.
